Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

被引：0
|
作者：
Yasuo Suzuki
Satoshi Motoya
Hiroyuki Hanai
Takayuki Matsumoto
Toshifumi Hibi
Anne M. Robinson
Nael M. Mostafa
Jingdong Chao
Vipin Arora
Anne Camez
Roopal B. Thakkar
Mamoru Watanabe
机构：
[1] Toho University Medical Center Sakura Hospital,IBD Center
[2] Sapporo Kosei General Hospital,Department of Gastroenterology
[3] Hamamatsu South Hospital,undefined
[4] Hyogo College of Medicine,undefined
[5] Kitasato Institute Hospital,undefined
[6] AbbVie,undefined
[7] AbbVie GmbH & Co KG,undefined
[8] Tokyo Medical and Dental University,undefined
来源：
Journal of Gastroenterology | 2014年 / 49卷
关键词：
Clinical remission; Japan; Ulcerative colitis; Mucosal healing; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 294
页数：11
相关论文
共 50 条
  • [41] Adalimumab Induction Therapy Improves Health-Related Quality of Life in Patients with Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Sandborn, William
    Thakkar, Roopal
    Lazar, Andreas
    Huang, Bidan
    Mulani, Parvez
    Chao, Jingdong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S441 - S442
  • [42] Rate of and Response to Dose Escalation in Patients Treated With Adalimumab for Moderately to Severely Active Ulcerative Colitis: Subanalysis of ULTRA 2
    Wolf, Douglas
    D'Haens, Geert
    Sandborn, William
    Colombel, Jean-Frederic
    Van Assche, Gert
    Lazar, Andreas
    Zhou, Qian
    Robinson, Anne
    Chao, Jingdong
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S619 - S619
  • [43] Time to Remission and Response in Adalimumab-treated Patients with Moderately to Severely Active Ulcerative Colitis from ULTRA 2
    Colombel, Jean-Frederic
    Plevy, Scott
    Sandborn, William
    D'Haens, Geert
    Robinson, Anne
    Petersson, J.
    Huang, Bidan
    Lazar, Andreas
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S505 - S505
  • [44] Efficacy of biologic therapies for biologic-naive Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
    Hibi, Toshifumi
    Kamae, Isao
    Pinton, Philippe
    Ursos, Lyann
    Iwakiri, Ryuichi
    Hather, Greg
    Patel, Haridarshan
    INTESTINAL RESEARCH, 2021, 19 (01) : 53 - +
  • [45] Efficacy and safety of adalimumab for the treatment of Japanese patients with moderately to severely active Crohn's disease: Results from a randomized controlled trial
    Hibi, Toshifumi
    Watanabe, Mamoru
    Camez, Anne
    Khan, Mahmudul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S414 - S415
  • [46] Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert
    Hanauer, Stephen
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Kampman, Wendy
    Lazar, Andreas
    Thakkar, Roopal
    GUT, 2011, 60 (06) : 780 - 787
  • [47] Cost-effectiveness of vedolizumab SC vs. adalimumab for moderately to severely active ulcerative colitis
    Diakite, I.
    Schultz, B.
    Carter, J.
    Snedecor, S.
    Turpin, R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S454 - S455
  • [48] Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis
    Schultz, Bob G.
    Diakite, Ibrahim
    Carter, John A.
    Snedecor, Sonya J.
    Turpin, Robin
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (11): : 1592 - 1600
  • [49] COST-EFFECTIVENESS OF VEDOLIZUMAB IV VERSUS ADALIMUMAB SC FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Schultz, Robert
    Diakite, Ibrahim
    Carter, John A.
    Snedecor, Sonya
    Turpin, Robin S.
    GASTROENTEROLOGY, 2020, 158 (06) : S658 - S658
  • [50] A PHASE 3 STUDY OF VEDOLIZUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Watanabe, Mamoru
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Igeta, Masataka
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2018, 154 (06) : S380 - S381
12345